| Financial Year |
March 31 2023 |
| Monetary Funds |
59,556,277.11 |
| Held-for-trading Financial Assets |
52,015,781.52 |
| Notes Receivable |
-- |
| Accounts Receivable |
8,879,578.38 |
| Advances to Suppliers |
-- |
| Other Receivables |
3,168,628.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
618,079.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
410,849.32 |
| Total Current Assets |
151,402,275.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
65,079,646.21 |
| Under-construction Projects |
21,635,524.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,212,641.93 |
| R&D expenses |
-- |
| Goodwill |
406,210.43 |
| Long-Term Deferred and Prepaid Expenses |
2,387,428.74 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
94,721,451.89 |
| Total Assets |
246,123,727.21 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,000,000.00 |
| Accounts Payable |
52,606,468.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,106,957.01 |
| Taxes Payable |
25,339,274.84 |
| Interest Payable |
-- |
| Dividend Payable |
291,457.00 |
| Other payables |
81,832,400.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
162,010,704.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,667,623.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,667,623.85 |
| Total Liabilities |
164,678,328.19 |
| Paid-In Capital(Or Share Stock) |
374,977,200.00 |
| Capital Surplus |
367,100,134.05 |
| Surplus Reserve |
43,268,878.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-701,900,813.19 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
81,445,399.02 |
| Owner's Equity（Stockholder's Equity） |
81,445,399.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
246,123,727.21 |
